Design, Synthesis, and Evaluation of Triazole Derivatives That Induce Nrf2 Dependent Gene Products and Inhibit the Keap1-Nrf2 Protein-Protein Interaction

被引：93
|
作者：
Bertrand, Helene C. [1 ]
Schaap, Marjolein [1 ]
Baird, Liam [2 ]
Georgakopoulos, Nikolaos D. [1 ]
Fowkes, Adrian [1 ]
Thiollier, Clarisse [1 ]
Kachi, Hiroko [1 ]
Dinkova-Kostova, Albena T. [2 ,3 ,4 ]
Wells, Geoff [1 ]
机构：
[1] UCL, UCL Sch Pharm, London WC1N 1AX, England
[2] Univ Dundee, Med Res Inst, Div Canc Res, Jacqui Wood Canc Ctr, Dundee DD1 9SY, Scotland
[3] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA
[4] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA
来源：
JOURNAL OF MEDICINAL CHEMISTRY | 2015年 / 58卷 / 18期
基金：
英国生物技术与生命科学研究理事会;
关键词：
RANDOMIZED CLINICAL-TRIAL; OXIDATIVE STRESS; PEPTIDE INHIBITORS; NRF2-KEAP1; COMPLEX; KELCH DOMAIN; DLG MOTIFS; BINDING; PATHWAY; UBIQUITINATION; DISCOVERY;
D O I：
10.1021/acs.jmedchem.5b00602
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
The transcription factor Nrf2 regulates the expression of a large network of cytoprotective and metabolic enzymes and proteins. Compounds that directly and reversibly inhibit the interaction between Nrf2 and its main negative regulator Keap1 are potential pharmacological agents for a range of disease types including neurodegenerative conditions and cancer. We describe the development of a series of 1,4-dipheny1-1,2,3-triazole compounds that inhibit the Nrf2-Keap1 protein protein interaction (PPI) in vitro and in live cells and up-regulate the expression of Nrf2-dependent gene products.
引用
收藏
页码：7186 / 7194
页数：9
相关论文
共 50 条
  • [21] ELECTROPHILES AND KEAP1-NRF2 PROTEIN-PROTEIN INTERACTION INHIBITORS FOR PREVENTION AND TREATMENT OF CHRONIC DISEASE
    Naidu, Sharadha Dayalan
    Dikovskaya, Dina
    Cafferkey, Annamarie J.
    Novak, Miroslav
    Suzuki, Takafumi
    Knatko, Elena V.
    Moore, Terry W.
    Wells, Geoffrey
    Dinkova-Kostova, Albena T.
    FREE RADICAL BIOLOGY AND MEDICINE, 2024, 218 : 3 - 3
  • [22] Synthesis of Keap1-phosphorylated p62 and Keap1-Nrf2 protein-protein interaction inhibitors and their inhibitory activity
    Yasuda, Daisuke
    Nakajima, Mao
    Yuasa, Akihiro
    Obata, Rika
    Takahashi, Kyoko
    Ohe, Tomoyuki
    Ichimura, Yoshinobu
    Komatsu, Masaaki
    Yamamoto, Masayuki
    Imamura, Riyo
    Kojima, Hirotatsu
    Okabe, Takayoshi
    Nagano, Tetsuo
    Mashino, Tadahiko
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 26 (24) : 5956 - 5959
  • [23] Cell penetrating peptides targeting the Nrf2/Keap1 protein-protein interaction
    Steel, Richard
    Cowan, Jonathan
    O'Connell, Maria A.
    Searcey, Mark
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 246
  • [24] Inhibiting the Keap1/Nrf2 Protein-Protein Interaction with Protein-Like Polymers
    Carrow, Kendal P.
    Hamilton, Haylee L.
    Hopps, Madeline P.
    Li, Yang
    Qiao, Baofu
    Payne, N. Connor
    Thompson, Matthew P.
    Zhang, Xiaoyu
    Magassa, Assa
    Fattah, Mara
    Agarwal, Shivangi
    Vincent, Michael P.
    Buyanova, Marina
    Bertin, Paul A.
    Mazitschek, Ralph
    Olvera de la Cruz, Monica
    Johnson, Delinda A.
    Johnson, Jeffrey A.
    Gianneschi, Nathan C.
    ADVANCED MATERIALS, 2024, 36 (21)
  • [25] Discovery of direct inhibitors of Keap1-Nrf2 protein-protein interaction as potential therapeutic and preventive agents
    Abed, Dhulfiqar Ali
    Goldstein, Melanie
    Albanyan, Haifa
    Jin, Huijuan
    Hu, Longqin
    ACTA PHARMACEUTICA SINICA B, 2015, 5 (04) : 285 - 299
  • [26] Modified Peptide Inhibitors of the Keap1-Nrf2 Protein-Protein Interaction Incorporating Unnatural Amino Acids
    Georgakopoulos, Nikolaos D.
    Talapatra, Sandeep K.
    Gatliff, Jemma
    Kozielski, Frank
    Wells, Geoff
    CHEMBIOCHEM, 2018, 19 (17) : 1810 - 1816
  • [27] Optimization Efforts for Identification of Novel Highly Potent Keap1-Nrf2 Protein-Protein Interaction Inhibitors
    Otake, Kazuki
    Hara, Yoshinori
    Ubukata, Minoru
    Inoue, Masafumi
    Nagahashi, Noboru
    Motoda, Dai
    Ogawa, Naoki
    Hantani, Yoshiji
    Hantani, Rie
    Adachi, Tsuyoshi
    Nomura, Akihiro
    Yamaguchi, Keishi
    Maekawa, Mariko
    Mamada, Hideaki
    Motomura, Takahisa
    Sato, Motohide
    Harada, Kazuhito
    JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (05) : 3741 - 3763
  • [28] Updated Research and Applications of Small Molecule Inhibitors of Keap1-Nrf2 Protein-Protein Interaction: a Review
    Zhuang, Chunlin
    Miao, Zhenyuan
    Sheng, Chunquan
    Zhang, Wannian
    CURRENT MEDICINAL CHEMISTRY, 2014, 21 (16) : 1861 - 1870
  • [29] Discovery of a small-molecule inhibitor and cellular probe of Keap1-Nrf2 protein-protein interaction
    Hu, Longqin
    Magesh, Sadagopan
    Chen, Lin
    Wang, Lili
    Lewis, Timothy A.
    Chen, Yu
    Khodier, Carol
    Inoyama, Daigo
    Beamer, Lesa J.
    Emge, Thomas J.
    Shen, Jian
    Kerrigan, John E.
    Ah-Ng Tony Kong
    Dandapani, Sivaraman
    Palmer, Michelle
    Schreiber, Stuart L.
    Munoz, Benito
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (10) : 3039 - 3043
  • [30] Computational Assessment of Carotenoids as Keap1-Nrf2 Protein-Protein Interaction Inhibitors: Implications for Antioxidant Strategies
    Medoro, Alessandro
    Jafar, Tassadaq Hussain
    Sallustio, Fabio
    Scapagnini, Giovanni
    Saso, Luciano
    Davinelli, Sergio
    BIOCHEMISTRY-MOSCOW, 2024, 89 (10) : 1681 - 1691
12345